Access cutting-edge epilepsy treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Access epilepsy specialists in Tucson at no cost
This study follows strict safety protocols and ethical guidelines
All study-related epilepsy treatment provided free
This clinical trial is designed to test whether a single image-guided intracerebral administration of inhibitory nerve cells, called interneurons (NRTX-1001), into subjects with drug-resistant unilateral mesial temporal lobe epilepsy (MTLE), with or without mesial temporal sclerosis (MTS), is safe (frequency of adverse events) and effective (seizure frequency). NRTX-1001 comprises human interneurons that secrete a neurotransmitter, gamma-aminobutyric acid (GABA).
Sponsor: Neurona Therapeutics
Check if you qualify for this epilepsy clinical trial in Tucson, AZ
If you're searching for epilepsy treatment options in Tucson, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced epilepsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.